Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
UK Startups and Innovation
13MAY

Rivan raises £25m for Europe's biggest SNG plant

3 min read
20:05UTC

A Wiltshire startup pulled IQ Capital, Plural, and a European founder-angel trio onto its cap table to build synthetic gas at 15MW scale.

← Back to State capital lands on UK tech in nine daysJump to analysis ↓
TechnologyDeveloping
Key takeaway

Rivan's angel syndicate shows UK cleantech can scale outside state programmes if European operator capital backs it.

Rivan, founded by Harvey Hodd, raised £25m on 20 April 2026 to build Project Steadfast, a 15MW synthetic natural gas plant in Wiltshire. IQ Capital led with Plural; angel investors included Matt Clifford of Entrepreneur First, Thomas Wolf of Hugging Face, and Markus Villig of Bolt. Total raised now stands at $46m, and the company has a commercial offtake partnership with Wales & West Utilities.

Synthetic natural gas (SNG) is methane manufactured from captured CO2 and green hydrogen rather than extracted from a well. The output is molecularly identical to fossil gas, meaning it runs on existing pipeline infrastructure, boilers, and industrial burners without replacement capex; that substitutability is the commercial proposition. Project Steadfast's 15MW scale makes it Europe's largest SNG facility and the first to inject SNG directly into the UK gas grid.

Four backers, four distinct European pedigrees. IQ Capital is a Cambridge deep-tech VC; Plural is a European fund founded by the Skype and Wise operators. The three angels each founded a category-defining European company: Clifford's Entrepreneur First runs the continent's largest talent-first accelerator; Wolf co-founded the AI platform Hugging Face; Villig built Bolt into Europe's largest ride-hailing operator by vehicle count. A cleantech startup pulling that mix of operator angels onto a grid-injection project is a signal about where European founder capital is migrating, and it is not toward the same US-dominated climate funds that dominated the last boom.

The cleantech vertical sits outside the UK's main targeted state-capital corridors. SAIU targets AI , ProQure targets quantum , LSIMF targets life sciences, and there is no equivalent multi-billion programme specifically for synthetic fuels. Rivan demonstrates that UK cleantech can still assemble material capital through VC plus founder-angel syndication at single-digit-£10m ticket sizes, though the ceiling on that mechanism is £25m, not £250m.

Deep Analysis

In plain English

Synthetic natural gas (SNG) is made by converting hydrogen into a gas that works exactly like the natural gas already in UK homes and factories. Rivan is building Europe's biggest factory for this process in Wiltshire, and it will be the first time this kind of gas has been pumped directly into the UK gas grid. The advantage is that industries using gas-powered furnaces or boilers do not need to change their equipment; they just switch to a cleaner version of the fuel they already use. The investors include the founders of Hugging Face and Bolt, two very well-known European tech companies, which is unusual for what is essentially an energy infrastructure project.

Deep Analysis
Root Causes

Natural gas demand from industries that cannot electrify; glass furnaces, ceramics, food processing, steel reheating; is projected to persist at 30-40% of current UK industrial gas consumption through 2040 per National Grid ESO's Future Energy Scenarios (2025); SNG from green hydrogen is the only currently technically viable substitute that does not require those industries to refit their combustion equipment.

The UK's hydrogen strategy (2021) allocated £240m to hydrogen production but did not create a mandatory blending target for the gas grid, leaving SNG injection commercially marginal without a voluntary green premium; Rivan's angel syndicate; Clifford, Wolf, Villig; reflects the project's dependence on conviction capital rather than policy-backed debt.

What could happen next?
  • Consequence

    Project Steadfast will be the first commercial test of whether the UK gas grid's metering infrastructure can issue Renewable Gas Guarantees of Origin for SNG at MW scale; if Wales and West Utilities cannot certify the injection, the project's revenue model collapses to commodity gas pricing and Rivan will need a Contracts for Difference application to reach Series B.

  • Opportunity

    A successful 15MW SNG injection at Wiltshire gives Rivan a replicable template for sites near industrial gas clusters; Teesside, Humber, Grangemouth; where hard-to-abate manufacturing demand is concentrated and grid injection capacity already exists, unlocking a pipeline of 10-15 further sites without new grid infrastructure.

Sources:City AM
Mentions:Rivan →Matt Clifford →Thomas Wolf →Markus Villig →Entrepreneur First →Hugging Face →Bolt →Wales →Cambridge →ProQure →Project Steadfast →Harvey Hodd →Wiltshire →Sovereign AI Unit →Venture Capital Trusts →Life Sciences Innovative Manufacturing Fund →
First Reported In

Update #2 · Britain's innovation pipe leaks at both ends

City AM· 22 Apr 2026
Read original →
Causes and effects
This Event
Rivan raises £25m for Europe's biggest SNG plant
Rivan's syndicate pairs UK deep-tech VC with three European category-defining founders, a pattern that routes scale-up validation to UK cleantech without VCT dependency.
Led to
Nyobolt hits £1bn on Symbotic-led Series C
IQ Capital's participation in Nyobolt Series C continues its pattern of anchoring Cambridge deeptech spinout rounds alongside strategics, as it did in the Rivan raise (ID:2702).
Occurred 6 May 2026
Read story →
Different Perspectives
Australian Department of Defence (AUKUS AI for Acoustics partner)
Australian Department of Defence (AUKUS AI for Acoustics partner)
Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US, and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May brings UK sovereign capital directly into a trilateral programme, which from Canberra's perspective places additional UK government skin-in-the-game on a programme Australia co-funds and co-develops.
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova participated alongside the BBB in Cytospire's oversubscribed £61m Series A on 5 May, demonstrating that the BBB's expanded direct mandate is attracting established European specialist biotech funds rather than replacing them. European VCs see the BBB's cornerstone position as a signal reducing UK biotech execution risk rather than crowding out private capital.
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Singapore's Temasek co-invested alongside the UK's SAIU in Isomorphic's $2.1bn round, treating the same Alphabet-majority company as an acceptable sovereign co-investment target. Temasek's participation normalises the structure: multiple sovereign wealth funds backed the same round, strengthening the precedent that UK-headquartered Alphabet subsidiaries qualify for state investment.
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet co-invested via GV and CapitalG in the same Isomorphic Series B round that received UK sovereign backing, placing US corporate capital and UK public capital in the same syndicate without any governance asymmetry. SAIU's minority stake validates Isomorphic's strategic value without constraining Alphabet's control over IP, geography, or exit decisions.
DSIT / Liz Kendall, Secretary of State for Science
DSIT / Liz Kendall, Secretary of State for Science
DSIT framed the Isomorphic investment as backing a British-founded and headquartered company advancing UK AI capability, and described the nine-day sovereign deployment sprint as evidence the government's industrial strategy is operational. The department has not addressed the ownership question, the absence of eligibility criteria, or the pace-versus-doctrine tension in the BBB mandate.
Beauhurst / UK startup data analysts
Beauhurst / UK startup data analysts
Five sub-£50m rounds closed in nine days with zero VCT-backed angel networks on any cap table, confirming the post-cut investor map is forming fast in the £4m–£40m band. The gap is structural: 36.7% of university spinouts raised below £500,000 in 2025, a tier neither the SAIU nor the BBB direct mandate touches.